Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (7668)	4/23/1998 12:10:00 PM
From: Hank	Read Replies (1) \| Respond to of 18691

OK. Now subtract out the placebo as background to give the true efficacy numbers for Vasomax. You get a range of 11%-29%. Might as well wack it with a hammer to make it swell.

To: BDR who wrote (7668)	4/23/1998 12:30:00 PM
From: Hank	Respond to of 18691

I also forgot to mention that Joe P. (ZONA's CEO) was quoted in todays IBD as saying that Vasomax will help 30% of men with ED. Looks like he's stretching the truth a bit since the highest efficacy range minus placebo is 29%. Given the fact that the true efficacy of any drug is usually less than indicated by clinical trials once disseminated to the patient population, the expected efficacy of Vasomax, if approved, would probably be less than 20 % (an average of the stated range). It's a mighty fine line those longs are walking.